BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2007928)

  • 1. Prolonged survival in patients with beta-thalassemia major treated with deferoxamine.
    Ehlers KH; Giardina PJ; Lesser ML; Engle MA; Hilgartner MW
    J Pediatr; 1991 Apr; 118(4 Pt 1):540-5. PubMed ID: 2007928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron chelation therapy to prevent poststroke cognitive impairments: role of diabetes and sex.
    Sakamuri SSVP; Sure VN; Katakam PVG
    Am J Physiol Heart Circ Physiol; 2023 Feb; 324(2):H210-H211. PubMed ID: 36607799
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.
    Brittenham GM; Griffith PM; Nienhuis AW; McLaren CE; Young NS; Tucker EE; Allen CJ; Farrell DE; Harris JW
    N Engl J Med; 1994 Sep; 331(9):567-73. PubMed ID: 8047080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and causes of death in patients with alpha and beta-thalassemia in Northern Thailand.
    Tantiworawit A; Kamolsripat T; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Rattarittamrong E; Norasetthada L; Fanhchaksai K; Charoenkwan P
    Ann Med; 2024 Dec; 56(1):2338246. PubMed ID: 38604224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac complications in thalassemia throughout the lifespan: Victories and challenges.
    Wood JC
    Ann N Y Acad Sci; 2023 Dec; 1530(1):64-73. PubMed ID: 37902424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review.
    Locke M; Reddy PS; Badawy SM
    Hemoglobin; 2022 Jul; 46(4):201-213. PubMed ID: 35930250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of a pharmacologic iron chelator reduces cartilage lesion development in the Dunkin-Hartley model of primary osteoarthritis.
    Burton LH; Afzali MF; Radakovich LB; Campbell MA; Culver LA; Olver CS; Santangelo KS
    Free Radic Biol Med; 2022 Feb; 179():47-58. PubMed ID: 34923104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol improves left ventricular diastolic dysfunction in patients with transfusion-dependent thalassemia.
    Silvilairat S; Charoenkwan P; Saekho S; Tantiworawit A; Chattipakorn N
    Ann Pediatr Cardiol; 2021; 14(2):152-158. PubMed ID: 34103853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells.
    Cromer MK; Camarena J; Martin RM; Lesch BJ; Vakulskas CA; Bode NM; Kurgan G; Collingwood MA; Rettig GR; Behlke MA; Lemgart VT; Zhang Y; Goyal A; Zhao F; Ponce E; Srifa W; Bak RO; Uchida N; Majeti R; Sheehan VA; Tisdale JF; Dever DP; Porteus MH
    Nat Med; 2021 Apr; 27(4):677-687. PubMed ID: 33737751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Quality of Life in Transfusion-dependent Thalassemia Patients Based on the PRECEDE Model: A Structural Equation Modeling Approach.
    Maheri M; Rohban A; Sadeghi R; Joveini H
    J Epidemiol Glob Health; 2020 Jun; 10(2):157-163. PubMed ID: 32538032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensorineural Hearing Loss and Its Relationship with Duration of Chelation Among Major β-Thalassemia Patients.
    Khan MA; Khan MA; Seedat AM; Khan M; Khuwaja SF; Kumar R; Usama SM; Fareed S
    Cureus; 2019 Aug; 11(8):e5465. PubMed ID: 31641562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report.
    Cooray SD; Heerasing NM; Selkrig LA; Subramaniam VN; Hamblin PS; McDonald CJ; McLean CA; McNamara E; Leet AS; Roberts SK
    J Med Case Rep; 2018 Jan; 12(1):18. PubMed ID: 29373985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A National Registry of Thalassemia in Turkey: Demographic and Disease Characteristics of Patients, Achievements, and Challenges in Prevention.
    Aydınok Y; Oymak Y; Atabay B; Aydoğan G; Yeşilipek A; Ünal S; Kılınç Y; Oflaz B; Akın M; Vergin C; Sezgin Evim M; Çalışkan Ü; Ünal Ş; Bay A; Kazancı E; İleri T; Atay D; Patıroğlu T; Kahraman S; Söker M; Akcan M; Akdeniz A; Büyükavcı M; Alanoğlu G; Bör Ö; Soyer N; Özdemir Karadaş N; Uysalol E; Türker M; Akçay A; Ocak S; Güneş AM; Tokgöz H; Ünal E; Tiftik N; Karakaş Z
    Turk J Haematol; 2018 Mar; 35(1):12-18. PubMed ID: 28404539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive MRI biomarkers for the early assessment of iron overload in a humanized mouse model of β-thalassemia.
    Jackson LH; Vlachodimitropoulou E; Shangaris P; Roberts TA; Ryan TM; Campbell-Washburn AE; David AL; Porter JB; Lythgoe MF; Stuckey DJ
    Sci Rep; 2017 Feb; 7():43439. PubMed ID: 28240317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives.
    Bayanzay K; Alzoebie L
    J Blood Med; 2016; 7():159-69. PubMed ID: 27540317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Bone Mineral Density in Thalassemia Major Patients with Healthy Controls.
    Meena MC; Hemal A; Satija M; Arora SK; Bano S
    Adv Hematol; 2015; 2015():648349. PubMed ID: 26880923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between serum ferritin level and diastolic cardiac function in patients with major β-thalassemia.
    Eghbali A; Taherahmadi H; Bagheri B; Nikanjam S; Ebrahimi L
    Iran J Ped Hematol Oncol; 2015; 5(2):83-8. PubMed ID: 26131346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment Hepatomegaly and liver Enzymes in 100 Patients with beta Thalassemia Major in Mashhad, Iran.
    Hashemizadeh H; Noori R; Kolagari Sh
    Iran J Ped Hematol Oncol; 2012; 2(4):171-7. PubMed ID: 24575259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA).
    Pennell DJ; Porter JB; Piga A; Lai Y; El-Beshlawy A; Belhoul KM; Elalfy M; Yesilipek A; Kilinç Y; Lawniczek T; Habr D; Weisskopf M; Zhang Y; Aydinok Y;
    Blood; 2014 Mar; 123(10):1447-54. PubMed ID: 24385534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of cardiac involvement in thalassemia: From bench to bedside perspective.
    Koonrungsesomboon N; Chattipakorn SC; Fucharoen S; Chattipakorn N
    World J Cardiol; 2013 Aug; 5(8):270-9. PubMed ID: 24009816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.